Immuno-oncology market set to grow in billions, but access concerns remain
Pharmaceutical Technology
MAY 26, 2023
This high compound annual growth rate of 23.6% was powered by the advent of immune-checkpoint inhibitors, added Chalk. Checkpoint modulators, cytokines and oncolytic viruses are also considered as part of the overall immune-oncology field. GlobalData is the parent company of Pharmaceutical Technology.
Let's personalize your content